Solara Active Pharma Sciences informs about outcome of board meeting

06 Feb 2026 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Solara Active Pharma Sciences has informed that the Board of Directors of the Company at their meeting held today, February 06, 2026, have considered and approved the following matters: 1. Amended the ‘Policy for Determining Materiality of Events / Information for Disclosure to Stock Exchanges’ in line with the amendments in Regulation 30 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015. The amended Policy is available on the Company’s website at solara.co.in/investor-relations/policies-and-guidelines/. 2.The Members of the Board has reviewed and adopted the revised ‘Policy for Governance of Related Party Transactions’ in compliance with amendment to the Regulation 23 of SEBI (Listing Obligations and Disclosure Requirement) Regulation, 2015 and any amendments thereto. The amended Policy is available on the Company’s website at solara.co.in/investor-relations/policies-and-guidelines/.

The above information is a part of company’s filings submitted to BSE. 

Solara Active Pharma Share Price

461.00 21.00 (4.77%)
25-Mar-2026 14:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.75
Dr. Reddys Lab 1305.55
Cipla 1252.35
Zydus Lifesciences 911.25
Lupin 2357.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×